Implantable cardioverter defibrillator: What a hospital practitioner needs to know
Tài liệu tham khảo
Schilling, 1998, Epidemiology and management of failed sudden cardiac death, Hosp Med, 59, 116
Yusuf, 1993, Critical review of the approaches to the prevention of sudden death, Am J Cardiol, 72, 51F, 10.1016/0002-9149(93)90963-D
Mudawi, 2009, Sudden cardiac death: history, aetiology and management, Br J Hosp Med (Lond), 70, 89, 10.12968/hmed.2009.70.2.38907
Mirowski, 1978, A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation, Circulation, 58, 90, 10.1161/01.CIR.58.1.90
Grimm, 1993, Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy, Circulation, 87, 1880, 10.1161/01.CIR.87.6.1880
Russo, 2003, Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?, Pacing Clin Electrophysiol, 26, 2289, 10.1111/j.1540-8159.2003.00361.x
Klein, 2003, Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial, J Cardiovasc Electrophysiol, 14, 940, 10.1046/j.1540-8167.2003.01554.x
Schaumann, 1999, Managing atrial tachyarrhythmias in patients with implantable cardioverter defibrillators, Am J Cardiol, 83, 214D, 10.1016/S0002-9149(98)01033-9
Raatikainen, 2008, Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up, Europace, 10, 1145, 10.1093/europace/eun203
Pacifico, 1999, Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group, N Engl J Med, 340, 1855, 10.1056/NEJM199906173402402
Saksena, 2008, The future of implantable defibrillator and cardiac resynchronization therapy trials, J Interv Card Electrophysiol, 23, 29, 10.1007/s10840-008-9302-6
Steinbrook, 2005, The controversy over Guidant's implantable defibrillators, N Engl J Med, 353, 221, 10.1056/NEJMp058158
Moss, 2005, Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol, Ann Noninvasive Electrocardiol, 10, 34, 10.1111/j.1542-474X.2005.00073.x
1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202
Connolly, 2000, Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297
Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748
Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601
Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503
Bansch, 2002, Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT), Circulation, 105, 1453, 10.1161/01.CIR.0000012350.99718.AD
Strickberger, 2003, Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT, J Am Coll Cardiol, 41, 1707, 10.1016/S0735-1097(03)00297-3
Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088
Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474
Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423
Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399
A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, et al., ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation May 27 2008;117(21):e350–408.